Multiple endocrine neoplasia type 2 historical perspective: Difference between revisions
Line 29: | Line 29: | ||
! style="background: #DCDCDC;" |1966 | ! style="background: #DCDCDC;" |1966 | ||
! style="background: #F5F5F5;" |Williams | ! style="background: #F5F5F5;" |Williams | ||
! style="background: #F5F5F5;" | | ! style="background: #F5F5F5;" |Reported a case of a patient with combination of mucosal neuromas, [[pheochromocytoma]] and [[medullary thyroid carcinoma]] | ||
|- | |- | ||
! style="background: #DCDCDC;" |1968 | ! style="background: #DCDCDC;" |1968 | ||
Line 35: | Line 35: | ||
! style="background: #F5F5F5;" |Introduced the term "multiple endocrine neoplasia" (MEN) to describe disorders featuring combinations of [[endocrine]] [[tumor]]s and proposed the terms '[[Wermer syndrome]]' for MEN 1 and '[[Sipple syndrome]]' for MEN 2 | ! style="background: #F5F5F5;" |Introduced the term "multiple endocrine neoplasia" (MEN) to describe disorders featuring combinations of [[endocrine]] [[tumor]]s and proposed the terms '[[Wermer syndrome]]' for MEN 1 and '[[Sipple syndrome]]' for MEN 2 | ||
|- | |- | ||
! style="background: #DCDCDC;" |1974 | ! style="background: #DCDCDC;" |1974 | ||
! style="background: #F5F5F5;" |Sizemore | ! style="background: #F5F5F5;" |Sizemore | ||
! style="background: #F5F5F5;" |Showed that the MEN 2 category included two groups of patients with MTC and [[pheochromocytoma]]: one with [[parathyroid]] [[disease]] and a normal appearance (MEN 2A) and the other without [[parathyroid]] [[disease]] but with mucosal neuromas and mesodermal abnormalities ([[MEN 2B]]) | ! style="background: #F5F5F5;" |Showed that the MEN 2 category included two groups of patients with MTC and [[pheochromocytoma]]: one with [[parathyroid]] [[disease]] and a normal appearance (MEN 2A) and the other without [[parathyroid]] [[disease]] but with mucosal neuromas and mesodermal abnormalities ([[MEN 2B]]) | ||
|- | |- | ||
! style="background: #DCDCDC;" |1993 | ! style="background: #DCDCDC;" |1993 | ||
! style="background: #F5F5F5;" | | ! style="background: #F5F5F5;" | | ||
! style="background: #F5F5F5;" |RET germline mutations were recognized as the causative molecular alterations in MEN 2 syndromes | ! style="background: #F5F5F5;" |RET germline mutations were recognized as the causative molecular alterations in MEN 2 syndromes | ||
|- | |- | ||
! style="background: #DCDCDC;" |1998 | ! style="background: #DCDCDC;" |1998 | ||
! style="background: #F5F5F5;" | | ! style="background: #F5F5F5;" | |
Revision as of 14:00, 21 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 historical perspective On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 historical perspective |
FDA on Multiple endocrine neoplasia type 2 historical perspective |
CDC on Multiple endocrine neoplasia type 2 historical perspective |
Multiple endocrine neoplasia type 2 historical perspective in the news |
Blogs on Multiple endocrine neoplasia type 2 historical perspective |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Years | Scientist | Contribution |
---|---|---|
1954 | Wermer | Reported that syndrome was transmitted as a dominant trait |
1959 | Hazard | Described medullary (solid) thyroid carcinoma |
1961 | Sipple | Described a combination of a pheochromocytoma, medullary thyroid carcinoma and parathyroid adenoma |
1965 | Schimke and Hartmann | Described a syndrome of medullary thyroid carcinoma with abundant amyloid stroma and pheochromocytoma [1] |
1966 | Williams | Reported a case of a patient with combination of mucosal neuromas, pheochromocytoma and medullary thyroid carcinoma |
1968 | Steiner | Introduced the term "multiple endocrine neoplasia" (MEN) to describe disorders featuring combinations of endocrine tumors and proposed the terms 'Wermer syndrome' for MEN 1 and 'Sipple syndrome' for MEN 2 |
1974 | Sizemore | Showed that the MEN 2 category included two groups of patients with MTC and pheochromocytoma: one with parathyroid disease and a normal appearance (MEN 2A) and the other without parathyroid disease but with mucosal neuromas and mesodermal abnormalities (MEN 2B) |
1993 | RET germline mutations were recognized as the causative molecular alterations in MEN 2 syndromes | |
1998 | MEN1 gene was cloned[2] |
References
- ↑ Schimke RN, Hartmann WH (1965). "Familial amyloid-producing medullary thyroid carcinoma and pheochromocytoma. A distinct genetic entity". Ann Intern Med. 63 (6): 1027–39. PMID 5844561.
- ↑ Guru SC, Manickam P, Crabtree JS, Olufemi SE, Agarwal SK, Debelenko LV. Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene. J Intern Med 243(6) 433-9